Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-307791

President & CEO sold 9,500 shares at $23.18 ($220,219)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Warmuth Markus President & CEO 2026-07-16 Sale −9,500 $23.18 $220,219 585,038 D: show line 1 in the form
Open-market sales · 9,500 sh · avg $23.18 · $220,219
Loading xslF345X06/ownership.xml…